Spiked Supplement Penalties May Predict Stronger Enforcement Approach
This article was originally published in The Tan Sheet
FDA and DoJ imposed a financial penalty and a prison sentence on the founder of NovaCare LLC, who pleaded guilty to spiking supplements. Industry stakeholders say the penalties could be a sign of coming enforcement strategy as FDA runs out of patience with spiked supplements.
You may also be interested in...
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.